Lungs of COVID-19 survivors teem with virus-fighting ‘memory’ cells
Even elderly survivors show a strong, persistent immune memory
Even elderly survivors show a strong, persistent immune memory
LJI-led Coronavirus Immunotherapeutic Consortium identifies antibody 'communities' with power to stop SARS-CoV-2 variants
Immune system memory stays strong 6+ months post-vaccination, similar to responses in recovered COVID-19 patients
Harnessing the combined power of Vitamin C and TET proteins may give scientists a leg up in treating autoimmune diseases
New LJI research could keep cancer-fighting T cells from burning out before the job is done
LJI researchers highlight the importance of T cell cross reactivity in stopping severe COVID-19 cases
LJI scientists develop new tool for understanding enzymatic activity linked to blood cancers and heart disease
Treating patients with anti-CTLA4 therapies prior to anti-PD1 treatment may be a promising strategy
New support from the American Cancer Society fuels research into the primary mutations behind many cancer types
National Cancer Institute support brings cancer researchers together to share key findings
New mouse models may shed light on the puzzling aspects of SARS-CoV-2 infection
New LJI review shows how T cells target more than 1,400 sites on SARS-CoV-2